Latest Insider Transactions at Intuitive Surgical Inc (ISRG)
This section provides a real-time view of insider transactions for Intuitive Surgical Inc (ISRG). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of INTUITIVE SURGICAL INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of INTUITIVE SURGICAL INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 26
2024
|
Amal M Johnson |
BUY
Exercise of conversion of derivative security
|
Direct |
6,696
+26.68%
|
$374,976
$56.97 P/Share
|
|
Jan 26
2024
|
Alan J Levy Director |
SELL
Open market or private sale
|
Direct |
2,000
-3.68%
|
$740,000
$370.2 P/Share
|
|
Jan 26
2024
|
Alan J Levy Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+3.45%
|
$244,000
$122.37 P/Share
|
|
Dec 13
2023
|
David J. Rosa President |
SELL
Bona fide gift
|
Direct |
1,572
-1.01%
|
-
|
|
Nov 16
2023
|
Amal M Johnson |
SELL
Open market or private sale
|
Direct |
9,567
-44.97%
|
$2,870,100
$300.0 P/Share
|
|
Nov 16
2023
|
Amal M Johnson |
BUY
Exercise of conversion of derivative security
|
Direct |
9,567
+31.02%
|
$392,247
$41.26 P/Share
|
|
Nov 16
2023
|
Myriam Curet EVP & Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
8,819
-92.83%
|
$2,645,700
$300.0 P/Share
|
|
Nov 16
2023
|
Myriam Curet EVP & Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,819
+48.13%
|
$1,543,325
$175.81 P/Share
|
|
Nov 14
2023
|
Alan J Levy Director |
SELL
Open market or private sale
|
Direct |
2,000
-7.32%
|
$580,000
$290.0 P/Share
|
|
Nov 14
2023
|
Alan J Levy Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+6.82%
|
$180,000
$90.49 P/Share
|
|
Nov 14
2023
|
Robert De Santis EVP & Chief Strategy & Corp Op |
SELL
Open market or private sale
|
Direct |
867
-5.59%
|
$251,430
$290.0 P/Share
|
|
Nov 14
2023
|
Robert De Santis EVP & Chief Strategy & Corp Op |
BUY
Exercise of conversion of derivative security
|
Direct |
867
+5.26%
|
$210,681
$243.97 P/Share
|
|
Oct 26
2023
|
Gary S Guthart CEO |
SELL
Open market or private sale
|
Direct |
27,385
-53.76%
|
$7,120,100
$260.11 P/Share
|
|
Oct 26
2023
|
Gary S Guthart CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
33,750
+39.85%
|
$1,653,750
$49.34 P/Share
|
|
Oct 24
2023
|
Gary S Guthart CEO |
SELL
Open market or private sale
|
Indirect |
4,960
-7.67%
|
$1,344,160
$271.93 P/Share
|
|
Oct 24
2023
|
Robert De Santis EVP & Chief Strategy & Corp Op |
SELL
Open market or private sale
|
Direct |
1,110
-4.82%
|
$301,920
$272.95 P/Share
|
|
Oct 24
2023
|
Robert De Santis EVP & Chief Strategy & Corp Op |
BUY
Exercise of conversion of derivative security
|
Direct |
1,110
+4.57%
|
$208,680
$188.86 P/Share
|
|
Oct 10
2023
|
Gary Loeb General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
904
-34.6%
|
$268,488
$297.83 P/Share
|
|
Oct 10
2023
|
Gary Loeb General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
2,613
+50.0%
|
-
|
|
Sep 14
2023
|
Amy L Ladd Director |
SELL
Open market or private sale
|
Direct |
500
-41.6%
|
$152,500
$305.68 P/Share
|
|
Aug 07
2023
|
Alan J Levy Director |
SELL
Open market or private sale
|
Direct |
2,000
-3.76%
|
$620,000
$310.0 P/Share
|
|
Aug 07
2023
|
Alan J Levy Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+3.59%
|
$160,000
$80.9 P/Share
|
|
Jul 31
2023
|
Gary S Guthart CEO |
SELL
Open market or private sale
|
Indirect |
4,960
-7.13%
|
$1,612,000
$325.89 P/Share
|
|
Jul 28
2023
|
Gary S Guthart CEO |
SELL
Bona fide gift
|
Indirect |
16,000
-1.34%
|
-
|
|
Jul 28
2023
|
Gary S Guthart CEO |
SELL
Open market or private sale
|
Direct |
50,314
-74.54%
|
$16,402,364
$326.76 P/Share
|
|
Jul 28
2023
|
Gary S Guthart CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
67,500
+50.0%
|
$2,835,000
$42.64 P/Share
|
|
Jul 25
2023
|
Robert De Santis EVP & Chief Strategy & Corp Op |
SELL
Open market or private sale
|
Direct |
2,535
-5.46%
|
$818,805
$323.13 P/Share
|
|
Jul 25
2023
|
Robert De Santis EVP & Chief Strategy & Corp Op |
BUY
Exercise of conversion of derivative security
|
Direct |
2,535
+5.15%
|
$567,840
$224.14 P/Share
|
|
Jun 14
2023
|
Marshall Mohr Executive VP Global Business S |
SELL
Open market or private sale
|
Direct |
11,250
-31.79%
|
$3,656,250
$325.0 P/Share
|
|
Jun 14
2023
|
Marshall Mohr Executive VP Global Business S |
BUY
Exercise of conversion of derivative security
|
Direct |
11,250
+24.12%
|
$663,750
$59.46 P/Share
|
|
Jun 14
2023
|
Craig H Barratt Director |
SELL
Open market or private sale
|
Direct |
1,567
-100.0%
|
$504,574
$322.78 P/Share
|
|
Jun 14
2023
|
Craig H Barratt Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,567
+50.0%
|
$64,247
$41.26 P/Share
|
|
Jun 14
2023
|
Robert De Santis EVP & Chief Strategy & Corp Op |
SELL
Open market or private sale
|
Direct |
2,443
-25.18%
|
$793,975
$325.0 P/Share
|
|
Jun 14
2023
|
Robert De Santis EVP & Chief Strategy & Corp Op |
BUY
Exercise of conversion of derivative security
|
Direct |
2,443
+20.12%
|
$708,470
$290.33 P/Share
|
|
May 11
2023
|
Robert De Santis EVP & Chief Strategy & Corp Op |
SELL
Payment of exercise price or tax liability
|
Direct |
169
-2.28%
|
$51,207
$303.47 P/Share
|
|
May 11
2023
|
Robert De Santis EVP & Chief Strategy & Corp Op |
BUY
Exercise of conversion of derivative security
|
Direct |
363
+4.66%
|
-
|
|
May 02
2023
|
Myriam Curet EVP & Chief Medical Officer |
SELL
Bona fide gift
|
Direct |
138
-42.2%
|
-
|
|
May 01
2023
|
Craig H Barratt Director |
SELL
Open market or private sale
|
Direct |
2,000
-100.0%
|
$612,000
$306.0 P/Share
|
|
May 01
2023
|
Craig H Barratt Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+50.0%
|
$82,000
$41.26 P/Share
|
|
Apr 28
2023
|
Mark J Rubash Director |
SELL
Open market or private sale
|
Direct |
7,323
-6.27%
|
$2,196,900
$300.0 P/Share
|
|
Apr 28
2023
|
Mark J Rubash Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,323
+5.85%
|
$1,237,587
$169.93 P/Share
|
|
Apr 27
2023
|
Mark J Rubash Director |
BUY
Exercise of conversion of derivative security
|
Direct |
482
+3.02%
|
-
|
|
Apr 27
2023
|
Monica P Reed Director |
BUY
Exercise of conversion of derivative security
|
Direct |
482
+31.73%
|
-
|
|
Apr 27
2023
|
Jami K Nachtsheim Director |
BUY
Exercise of conversion of derivative security
|
Direct |
482
+8.69%
|
-
|
|
Apr 27
2023
|
Amy L Ladd Director |
BUY
Exercise of conversion of derivative security
|
Direct |
482
+28.62%
|
-
|
|
Apr 27
2023
|
Alan J Levy Director |
BUY
Exercise of conversion of derivative security
|
Direct |
482
+1.87%
|
-
|
|
Apr 27
2023
|
Keith R Leonard Director |
BUY
Exercise of conversion of derivative security
|
Direct |
482
+11.85%
|
-
|
|
Apr 27
2023
|
Joseph C Beery Director |
BUY
Exercise of conversion of derivative security
|
Direct |
482
+21.1%
|
-
|
|
Apr 27
2023
|
Craig H Barratt Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
655
+2.52%
|
-
|
|
Apr 27
2023
|
Don R Kania Director |
BUY
Exercise of conversion of derivative security
|
Direct |
482
+12.85%
|
-
|